The pivotal role of NOX2 in antimicrobial defense is highlighted by the striking susceptibility to bacterial and fungal infections observed in patients with chronic granulomatous disease (CGD), which is a rare genetic disorder caused by deficiency in one of the principal components of NOX2. Here, CYBB is linked to chronic granulomatous disease.